Organogenesis Holdings Inc.
ORGO
$4.88
$0.214.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 7.67M | 12.33M | -17.04M | -2.10M | -568.00K |
| Total Depreciation and Amortization | 4.45M | 4.40M | 4.20M | 3.97M | 4.21M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.59M | 5.81M | 25.14M | 8.67M | 9.62M |
| Change in Net Operating Assets | -6.78M | -13.85M | -7.56M | -20.70M | -2.65M |
| Cash from Operations | 10.94M | 8.70M | 4.74M | -10.16M | 10.61M |
| Capital Expenditure | -3.36M | -2.57M | -1.88M | -2.22M | -3.32M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.36M | -2.57M | -1.88M | -2.22M | -3.32M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -62.62M | -1.68M | -1.67M | -1.67M | -1.78M |
| Issuance of Common Stock | 1.06M | 5.00K | 0.00 | 180.00K | 1.00K |
| Repurchase of Common Stock | -25.48M | -- | -54.00K | -1.12M | -- |
| Issuance of Preferred Stock | 120.69M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 33.65M | -1.68M | -1.73M | -2.61M | -1.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 41.23M | 4.45M | 1.13M | -14.99M | 5.51M |